Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1519176 (
PSA
)
5,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
SWI3
-related gene product (
SRG3
), a component of the mouse SWI/SNF complex, has been suggested to have an alternative function. Here, we demonstrate that in the prostate transactivation of the androgen receptor (AR) is modulated by
SRG3
in multiple ways. The expression of
SRG3
, which is developmentally regulated in the prostate, is induced by androgen through AR.
SRG3
in turn enhances the transactivation of AR, providing a positive feedback regulatory loop. The
SRG3
coactivation of AR transactivation is achieved through the recruitment of coactivator SRC-1, the protein level of which is upregulated by
SRG3
, providing another pathway of positive regulation. Interestingly,
SRG3
coactivation of AR transactivation is fully functional in BRG1/BRM-deficient C33A cells and the AR/
SRG3
/SRC-1 complex formed in vivo contains neither BRG1 nor BRM protein, suggesting the possibility of an
SRG3
function independent of the SWI/SNF complex. Importantly, the AR/
SRG3
/SRC-1 complex occupies androgen response elements on the endogenous
SRG3
and
PSA
promoter in an androgen-dependent manner in mouse prostate and LNCaP cells, respectively, inducing gene expression. These results suggest that the multiple positive regulatory mechanisms of AR transactivation by
SRG3
may be important for the rapid proliferation of prostate cells during prostate development and regeneration.
...
PMID:Modulation of androgen receptor transactivation by the SWI3-related gene product (SRG3) in multiple ways. 1592 3